Stock ABBV ABBVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News AbbVie Inc.

Equities

ABBV

US00287Y1091

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-30 pm EDT 		5-day change 1st Jan Change
156.3 USD +0.98% Intraday chart for AbbVie Inc. -1.23% +0.86%
May. 30 OSE Immuno: towards an evolution of the Board of Directors CF
May. 23 AbbVie Completes Acquisition of Landos Biopharma MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
PR
OSE Immuno: towards an evolution of the Board of Directors
CF
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
AQ
AbbVie Completes Acquisition of Landos Biopharma
MT
AbbVie Inc. completed the acquisition of Landos Biopharma, Inc. from a group of shareholders.
CI
Strides Pharma Arm Gets US FDA's Approval for Generic Stomach Ulcer Drug
MT
BaseLaunch announced that it has received funding from AbbVie Inc.
CI
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
AQ
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week
AQ
Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target
MT
ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta...
Our Logo
Transcript : AbbVie Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM
Medincell: share price falls after disappointing clinical study
CF
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders
MT
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
PR
Medincell: share price rises on resumption of trading
CF
Declaration of Voting Results of the AbbVie Inc
CI
Declaration of Voting Results of the AbbVie Inc
CI
Declaration of Voting Results of the AbbVie Inc
CI
AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABBV Stock
  4. News AbbVie Inc.